FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:238-239 January 21, 1999 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Sharer, N. PubMed Citation

To the Editor: In the September 3 issue, Sharer et al.¹ and Cohn et al.² reported an association between chronic pancreatitis and mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Sharer et al. concluded that none of their patients met the diagnostic criteria for cystic fibrosis, whereas Cohn et al. identified one patient as having an "atypical cystic fibrosis phenotype." The diagnostic criteria established by a consensus panel of the Cystic Fibrosis Foundation³ require one or more characteristic phenotypic features and one of three laboratory findings: an elevated sweat chloride concentration on two occasions, the identification . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Friedman, K. J., Silverman, L. M. (1999). Cystic Fibrosis Syndrome: A New Paradigm for Inherited Disorders and Implications for Molecular Diagnostics. Clin. Chem. 45: 929-931 [Full Text]  
• Malats, N., Real, F. X., Sharer, N. M., Schwartz, M. J. (1999). Correction: Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis. NEJM 340: 1592-1593 [Full Text]